Latest News about INCY
Recent news which mentions INCY
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
December 07, 2023
From Benzinga
Goldman Sachs Downgrades Incyte Amid Concerns Over Jakafi Studies, Competitiveness
November 21, 2023
Tickers
INCY
From Benzinga
3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024
November 12, 2023
From InvestorPlace
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
November 09, 2023
From InvestorPlace
Quant Ratings Updated on 73 Stocks
September 26, 2023
From InvestorPlace
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
September 20, 2023
From InvestorPlace
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
September 18, 2023
From Benzinga
Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share
August 01, 2023
Tickers
INCY
From Benzinga
Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings
July 25, 2023
From Benzinga
From Benzinga
From Benzinga
'I Don't Want You To Touch That': Cramer Rejects Stock Down 32% Over Past Month, Prefers Tesla
July 19, 2023
From Benzinga
From Benzinga
2 Low-Priced Stocks That Could Make You Richer
June 26, 2023
From Motley Fool
From MarketWatch
From Benzinga
From Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
April 19, 2023
From InvestorPlace
Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target
April 10, 2023
Tickers
INCY
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.